Dr Ben Cons is a Pharmaceutical and Healthcare leader with a proven track record and more than 30 years experience in pharmaceutical R&D & commercialization in the Biotech, Pharmaceutical and Financing sectors.

An entrepreneur who designs, builds and operates business solutions across the international pharmaceutical community to accelerate product development, maximize product lifecycle value and create optimum healthcare solutions.

He previously spent 20 years with the NYSE listed pharmaceutical services company IQVIA and the associated NovaQuest investment fund. Currently Ben is a Special Partner at the private equity fund Vitruvian, Investor Director at Immune Regulation a clinical stage drug development biotechnology company, Board Advisor to the Scottish start up Talking Medicines, Investment Member of the private capital group 24 Haymarket, and an Investment Panel Member Future Care Capital a charity focusing on future health and social care policy and a Mentor at Southampton University Future Worlds.